Engineering bacterial surfaces with glucan nanofilms creates a potent vaccine platform against invasive fungal infections
Peer-Reviewed Publication
Updates every hour. Last Updated: 24-Oct-2026 23:17 ET (25-Oct-2026 03:17 GMT/UTC)
Invasive fungal infections induced by Candida species are becoming an urgent threat to global health. While a series of antifungal vaccines have been developed, their efficiency is frequently compromised by the failure of immune stimulation. In this study, a novel antifungal vaccine was constructed by assembling β-glucan with the Candida albicans antigen candidalysin on the surface of the genetically engineered Escherichia coli strain EcS. This co-assembly was mediated by the cell surface-exposed artificial glucan-binding protein CipC-mCherry-CipC, leading to the formation of the surface glucan nanofilm with a thickness of ~ 80 nm. Upon coincubation with macrophages, the vaccine efficiently escapes from the lysosomes, leading to enhanced production of reactive oxygen species (ROS) and macrophage maturation. After mouse immunization, the vaccine persists longer in lymph nodes than free candidalysin or the glucan-free complex, and induces higher levels of CD4+, CD8+, TNFα+/CD4+ and IFNγ+/CD4+ T cells in the spleen. In a murine model of invasive fungal infection,immunization with this vaccine remarkably increases the survival rate, reduces the kidney fungal burdens and attenuates inflammatory responses. This bioengineering strategy offers a potentially viable approach for developing co-assembled whole-cell vaccines and can be extended to leverage bacterial carriers for surface antigen display. The vaccine acts not only as antigens but also as adjuvants, thereby eliciting strong and specific protective immunity against invasive fungal infections.
The Lasker Foundation today announced the winners of its 2026 Lasker Awards: Emmanuel Mignot (Stanford University School of Medicine) and Masashi Yanagisawa (University of Tsukuba) will receive the Albert Lasker Basic Medical Research Award; Kunihiro Hattori, Takehisa Kitazawa, and Tomoyuki Igawa (Chugai Pharmaceutical) will receive the Lasker~DeBakey Clinical Medical Research Award; and Michael J. Fox (The Michael J. Fox Foundation for Parkinson’s Research) will receive the Lasker~Bloomberg Public Service Award.
New study finds that widespread underreporting of Covid-19 deaths cannot be explained simply by differences in countries’ ability to count and record deaths. Across 134 countries and territories, an estimated 45%–55% of governments misreported Covid mortality, with underreporting far more common than overreporting. The study provides comparable country-level data of the extent of misinformation for researchers and policymakers. The findings point to a broader lesson beyond the pandemic: strong institutions and an informed public can play an important role in protecting the reliability of official information.
The study, conducted by Biplab Debnath and Shaileyee Das and published in Current Agricultural Sciences, argues that combining microbial biofertilizers with biochar — both made from waste — offers more benefit to soil and crops than either treatment alone.